Literature DB >> 15452413

Neuropsychological correlates of the PANSS Cognitive Factor.

T S Ehmann1, I Khanbhai, G W Macewan, G N Smith, W G Honer, S Flynn, S Altman.   

Abstract

OBJECTIVE: Factor analytic studies of the Positive and Negative Syndrome Scale (PANSS) have consistently isolated a factor that is frequently labeled as 'cognitive'. The present study sought to further explore the factor by examining the relationships between 4 versions of the cognitive factor and a set of neuropsychological tests.
METHOD: Thirty-seven inpatients diagnosed with schizophrenia or schizoaffective disorder were assessed with the PANSS and neuropsychological measures.
RESULTS: Verbal intelligence and verbal memory were found to be most closely associated with cognitive factor scores. A global rating of illness severity showed greater relationships to cognitive variables than any cognitive factor.
CONCLUSIONS: The PANSS cognitive factor may reflect verbal ability and memory, but is not sufficiently comprehensive to be considered as a replacement for direct assessment of cognitive functioning.

Entities:  

Mesh:

Year:  2004        PMID: 15452413     DOI: 10.1159/000081022

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  4 in total

1.  Inflammation in individuals with schizophrenia - Implications for neurocognition and daily function.

Authors:  Sophia Kogan; Luz H Ospina; David Kimhy
Journal:  Brain Behav Immun       Date:  2018-09-12       Impact factor: 7.217

2.  From Memories of Past Experiences to Present Motivation? A Meta-analysis on the Association Between Episodic Memory and Negative Symptoms in People With Psychosis.

Authors:  Matthias Pillny; Katarina Krkovic; Laura Buck; Tania M Lincoln
Journal:  Schizophr Bull       Date:  2022-03-01       Impact factor: 7.348

3.  Matrix Metalloproteinase 9 Blood Alterations in Patients With Schizophrenia Spectrum Disorders: A Systematic Review and Meta-Analysis.

Authors:  Georgios Schoretsanitis; Renato de Filippis; Maria Ntogka; Stefan Leucht; Christoph U Correll; John M Kane
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

4.  Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition.

Authors:  Slavica Minic Janicijevic; Ivan P Jovanovic; Nevena M Gajovic; Milena M Jurisevic; Monojit Debnath; Nebojsa N Arsenijevic; Milica M Borovcanin
Journal:  World J Psychiatry       Date:  2022-09-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.